CIK 0001427925 · Non-accelerated filer<br>Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 412193603
- Phone
- 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-14 | Palmer Pamela P Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +108,000 | 108,000 | ||
| 2024-02-14 | Dasu Badri N Chief Engineering Officer | Grant or award | +14,667 | 31,820 | ||
| 2024-02-14 | Dasu Badri N Chief Engineering Officer | Grant or award · Stock Option (Right to Buy) | +88,000 | 88,000 | ||
| 2024-02-14 | ASADORIAN RAFFI Chief Financial Officer | Grant or award | +18,000 | 38,291 | ||
| 2024-02-14 | ASADORIAN RAFFI Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +108,000 | 108,000 | ||
| 2024-02-14 | Angotti Vincent J. Chief Executive Officer | Grant or award | +58,667 | 153,429 | ||
| 2024-02-14 | Angotti Vincent J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +352,000 | 352,000 | ||
| 2024-02-11 | Dasu Badri N Chief Engineering Officer | Shares withheld for taxes | −809 | $1.10 | $890 | 17,153 |
| 2024-02-11 | Palmer Pamela P Chief Medical Officer | Shares withheld for taxes | −801 | $1.10 | $881 | 35,344 |
| 2024-02-11 | ASADORIAN RAFFI Chief Financial Officer | Shares withheld for taxes | −895 | $1.10 | $985 | 20,291 |
| 2024-02-11 | Angotti Vincent J. Chief Executive Officer | Shares withheld for taxes | −3,723 | $1.10 | $4K | 94,762 |
| 2024-02-10 | Dasu Badri N Chief Engineering Officer | Shares withheld for taxes | −809 | $1.10 | $890 | 17,962 |
| 2024-02-10 | Palmer Pamela P Chief Medical Officer | Shares withheld for taxes | −801 | $1.10 | $881 | 36,145 |
| 2024-02-10 | ASADORIAN RAFFI Chief Financial Officer | Shares withheld for taxes | −895 | $1.10 | $985 | 21,186 |
| 2024-02-10 | Angotti Vincent J. Chief Executive Officer | Shares withheld for taxes | −3,320 | $1.10 | $4K | 98,485 |
| 2024-01-22 | Nantahala Capital Management, LLC 10% owner | Returned to the company · 2023 Series A Warrants | −2,205,883 | 0 | ||
| 2024-01-22 | Nantahala Capital Management, LLC 10% owner | Returned to the company · 2023 Series B Warrants | −2,205,883 | 0 | ||
| 2024-01-22 | Nantahala Capital Management, LLC 10% owner | Grant or award · 2023 Series A Warrants | +2,205,883 | 2,205,883 | ||
| 2024-01-22 | Nantahala Capital Management, LLC 10% owner | Grant or award · 2023 Series B Warrants | +2,205,883 | 2,205,883 | ||
| 2024-01-22 | Nantahala Capital Management, LLC 10% owner | Grant or award · 2024 Pre-Funded Warrants | +6,168,832 | $0.77 | $4.7M | 6,168,832 |
Page 6 of 9 · 179 trades